Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05365425
PHASE4
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Sponsor: Seoul National University Bundang Hospital
View on ClinicalTrials.gov
Summary
This is a randomized controlled study to assess the effect of choline fenofibrate compared with policosanol in Korean T2DM patients with asymptomatic atherosclerosis.
Official title: Effect of Choline Fenofibrate on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes and Combined Dyslipidemia
Key Details
Gender
All
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
56
Start Date
2023-06-01
Completion Date
2026-12-31
Last Updated
2024-05-01
Healthy Volunteers
No
Interventions
DRUG
Choline fenofibrate
choline fenofibrate 178.8mg (135mg as fenofibric acid)
DRUG
Policosanol
policosanol 10mg
Locations (1)
SNUBH
Seongnam-si, Gyeonggi-do, South Korea